May 5th, 2020
•We present a model of ischemic heart disease using cardiomyocytes derived from human induced pluripotent stem cells, together with a method for quantitative evaluation of tissue damage caused by ischemia. This model can provide a useful platform for drug screening and further research on ischemic heart disease.
Related Videos
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Assessment of Cardiac Function and Myocardial Morphology Using Small Animal Look-locker Inversion Recovery (SALLI) MRI in Rats
Implantation of Total Artificial Heart in Congenital Heart Disease
A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases
Demonstration of the Rat Ischemic Skin Wound Model
Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Isometric Contractility Measurement of the Mouse Mesenteric Artery Using Wire Myography
Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model
Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
Electromechanical Assessment of Optogenetically Modulated Cardiomyocyte Activity
Copyright © 2024 MyJoVE Corporation. 판권 소유